Skip to main content
. 2021 Nov 17;77(10):960–967. doi: 10.1136/thoraxjnl-2020-216475

Table 1.

Baseline demographics of the study population

Parameters Patients with bronchiectasis
N=34
Healthy volunteers
N=6
Mild
n=10
Moderate
n=15
Severe
n=9
Age (years) 55 (4.1) 65 (2.2) 64 (2.2) 52 (6.8)
Biological sex (% female) 40 60 22 80
Aetiology
 Idiopathic 10 (100%) 12 (80%) 6 (67%)
 Postinfective 3 (20%) 3 (33%)
Total WCC (×109/L) 6 (0.5) 6.3 (0.4) 9.3 (1.1) 5.9 (0.5)
Neutrophils 3.3 (0.3) 4.1 (0.3) 6.6 (1.1) 3.5 (0.3)
Eosinophils 0.2 (0.04) 0.3 (0.07) 0.2 (0.06) 0.2 (0.06)
Monocytes 0.5 (0.03) 0.6 (0.05) 0.7 (1) 0.5 (0.05)
ESR (mm/hour) 6.7 (1.8) 13.2 (2.9) 19.6 (6.8) 4.8 (1)
CRP (mg/L) 2.8 (0.5) 4 (1) 16 (7.4) 3.2 (1.1)
FEV1 % predicted (L) 95 (5.5) 82 (4) 55 (6.5)
FVC % predicted (L) 111 (6) 97 (4) 84 (6)
TLCO % predicted (SI) 94% (4.9) 82% (4.2.) 74% (7.8)
KCO % predicted (SI) 106% (4.5) 97% (3.7) 100% (7.2)
Chronic colonisation 5 (50%) 12 (86%) 8 (89%)
Exacerbations in the last year 0.4 (0.3) 2.4 (0.5) 4.2 (0.9)
Hospital admissions in the last year 0 0.05 (0.05) 0.7 (0.2)

Data presented as mean (±SE of mean).

CRP, C reactive protein; ESR, erythrocyte sedimentation rate; FEV1, forced expiratory volume in 1 s; FVC, forced vital capacity; KCO, transfer coefficient corrected for alveolar volume; TLCO, transfer factor for the lung for carbon monoxide; WCC, white cell count.